Spero Therapeutics, Inc.

SPRONasdaq· Pharmaceutical Preparations

Price History

Revenue

$12.6M

▲ 3292.5% YoY

Net Income

$8.6M

▲ 112.5% YoY

EPS

$0.15

▲ 111.8% YoY

Cash

$40.3M

▼ 23.9% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.